Pradžia › Geografinė atrofija › Arizona
Geografinė atrofija klinikiniai tyrimai Arizona
5 tyrimai dėl Geografinė atrofija ieško dalyvių vietose Arizona.
Miestai Arizona
Oficialus tyrimo tekstas (anglų kalba)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Associates Southwest PC, Tucson
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Associated Retina Consultants - PHX, Gilbert
- Associated Retina Consultants, Phoenix
Renkami dalyviai1/2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Associated Retina Consultants - Peoria- Site Number : 8400011, Peoria
- Retina Macula Institute of Arizona- Site Number : 8400028, Scottsdale
Renkami dalyviai1/2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Barnet Dulaney Perkins Eye Center-Ophthamalogy, Chandler
- Barnet Dulaney Perkins Eye Center, Phoenix
- Associated Retina Consultants, Phoenix
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Associated Retina Consultants, Gilbert
- Associated Retina Consultants, Phoenix
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.